AlphaYouSO
Insider selling
Stephanie Okey sold $246K of Crinetics Pharmaceuticals, Inc. (CRNX) stock
Stephanie Okey, Dir of Crinetics Pharmaceuticals, Inc. (CRNX), sold 6,900 shares of CRNX stock worth $246K, per an SEC Form 4 filed Jun 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 17, 2026, 1 day before it was made public.
- Traded
- Jun 17, 2026
- Disclosed
- Jun 18, 2026
- Filing delay
- 1 day
- Role
- Dir
- Source
- SEC Form 4
More CRNX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.